Tuesday, 27 January 2015

Research into brain control of liver lipid production could cause break in obesity, diabetes treatment



by Cait Wills


Jessica Yue. Credit: Faculty of Medicine & Dentistry, University of Alberta


Ways of keeping the heart healthy has widened, with the discovery that the brain can help fight off hardening of the arteries.


Atherosclerosis—hardening and narrowing of the —can be caused by fat build up that causes plaque deposits, and is one of the main causes of . Jessica Yue, a newly recruited researcher in the Department of Physiology in the Faculty of Medicine & Dentistry, has shown a link between how the can regulate fat metabolism, potentially stopping the development of this disease risk factor in and diabetes.


Her findings, published this month in Nature Communications, the online version of the high-impact Nature publication, outlines how the brain can use the presence of fatty acids, which are building blocks of fat molecules, to trigger the liver to reduce its own lipid production.


"We know that when there is dyslipidemia, or an abnormal amount of fat in the bloodstream, it's dangerous for health—largely because this can lead to obesity, obesity-related disorders such as Type 2 diabetes, and ," says Yue, and that "if you can find ways to lower fats in the bloodstream, it helps to lower these chances of diabetes and cardiovascular disease as a result of this atherosclerosis."


Yue trained at the Toronto General Research Institute under Tony Lam, where she was a recipient of fellowships from the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association. With her associates in Toronto and with Peter Light, professor of pharmacology in the Faculty of Medicine & Dentistry, she looked at how the infusion of oleic acid, a naturally occurring monounsaturated fatty acid, in the brain "triggers" a signal from the hypothalamus to the liver to lower its fat secretion, which Yue says is a "triglyceride-rich, very-low-density lipoprotein. Light is the co-author of Yue's paper in Nature Communications and is the director of the Alberta Diabetes Institute (ADI), where Yue is applying for membership.


"This fat complex is the kind of lipoprotein that is dangerous when its levels in the blood are elevated because it promotes atherosclerosis," she says.


The catch, though, is that this "trigger" doesn't work in obesity, a setting in which blood lipid levels are usually high. "In a model of diet-induced obesity, which then leads to insulin resistance and pre-diabetes, oleic acid no longer provides the fat-lowering trigger to the liver." Yue's findings, though, demonstrate how this faulty signal can be bypassed, unveiling potentially other ways to trigger this same function in obese patients.


This study could potentially impact how obesity and diabetes are treated, says Yue, which is the focus of her future research.


The next steps, she says, will be to look at how the brain can sense other compounds to regulate not only liver secretion of fats, but also liver glucose production, a significant contributing factor to diabetes. As a member of the Group on Molecular and Cell Biology of Lipids and with the strength of the ADI, she feels enthusiastic and inspired by her new research environment at the University of Alberta.


"It's a big field and it's emerging," says Yue about neuroscience research in the areas of metabolic disease. "Whereas the peripheral organs have gained a lot of attention in terms of how they release glucose and lipids, it's exciting to see that within the last decade and a half that the brain now is emerging as an organ that has a lot of control over our health."



More information: Nature Communications, http://ift.tt/1AZlbnD 6970.html#affil-auth


Medical Xpress on facebook

Related Stories


Researchers uncover more clues to how drug reverses obesity, diabetes, fatty liver disease


Jan 12, 2015



Researchers at the University of Michigan have identified how a promising drug in clinical trials for the treatment of obesity and related metabolic disorders improves the metabolism of sugar by generating a new signal between ...



Diabetes debate: Triglycerides form in liver despite insulin resistance


Jan 05, 2015



Solving one of the great mysteries of type 2 diabetes, a team of Yale researchers found that triglycerides, a type of fat in the blood and liver, are produced in the liver independent of insulin action in ...



Newly discovered hormone with potential treatment for obesity, type 2 diabetes, liver disease


Nov 17, 2014



Researchers at the University of Michigan have discovered how a previously unknown hormone serves as a messenger from fat cells to the liver and are investigating the potential of developing a new treatment ...



Pellino 3 protein may prevent development of obesity-driven diabetes


Jan 12, 2015



Maynooth University scientists have identified a protein in the body that may have the potential to prevent the development of obesity-driven diabetes.



Scientists identify hormone that reduces calorie burning, contributes to obesity


Dec 08, 2014



Researchers from McMaster University have identified an important hormone that is elevated in obese people and contributes to obesity and diabetes by inhibiting brown fat activity.



Recommended for you




Using stem cells to grow new hair


2 hours ago



In a new study from Sanford-Burnham Medical Research Institute (Sanford-Burnham), researchers have used human pluripotent stem cells to generate new hair. The study represents the first step toward the development ...





Human stem cells could one day be regulated to replace aged, damaged, and missing tissues


4 hours ago



When a salamander loses a tail, it grows a new one. What's the difference, MIT biologist Peter Reddien PhD '02 wondered, between a wound that severs a salamander's tail and one that severs a human spinal ...



Scientists find drug candidates can block cell-death pathway associated with Parkinson's


7 hours ago



In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's ...





Antiangiogenesis drugs could make major improvement in tuberculosis treatment


21 hours ago



Use of the same antiangiogenesis drugs that have improved treatment of some cancers could also help surmount persistent difficulties in treating tuberculosis (TB). In their PNAS Early Edition report, invest ...





Collagen fibres not only passively support bone, tendons and ligaments, but also actively contract


Jan 26, 2015



The bodies of humans and animals owe their strength especially to a fibrous structural protein called collagen. Collagen is abundant in bones, tendons, ligaments and skin. Water, a substance that is not often ...





Possible therapeutic target for common, but mysterious brain blood vessel disorder


Jan 26, 2015



Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, ...



User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here to reset your password.

Sign in to get notified via email when new comments are made.






by Cait Wills


Jessica Yue. Credit: Faculty of Medicine & Dentistry, University of Alberta


Ways of keeping the heart healthy has widened, with the discovery that the brain can help fight off hardening of the arteries.


Atherosclerosis—hardening and narrowing of the —can be caused by fat build up that causes plaque deposits, and is one of the main causes of . Jessica Yue, a newly recruited researcher in the Department of Physiology in the Faculty of Medicine & Dentistry, has shown a link between how the can regulate fat metabolism, potentially stopping the development of this disease risk factor in and diabetes.


Her findings, published this month in Nature Communications, the online version of the high-impact Nature publication, outlines how the brain can use the presence of fatty acids, which are building blocks of fat molecules, to trigger the liver to reduce its own lipid production.


"We know that when there is dyslipidemia, or an abnormal amount of fat in the bloodstream, it's dangerous for health—largely because this can lead to obesity, obesity-related disorders such as Type 2 diabetes, and ," says Yue, and that "if you can find ways to lower fats in the bloodstream, it helps to lower these chances of diabetes and cardiovascular disease as a result of this atherosclerosis."


Yue trained at the Toronto General Research Institute under Tony Lam, where she was a recipient of fellowships from the Canadian Institutes of Health Research (CIHR) and the Canadian Diabetes Association. With her associates in Toronto and with Peter Light, professor of pharmacology in the Faculty of Medicine & Dentistry, she looked at how the infusion of oleic acid, a naturally occurring monounsaturated fatty acid, in the brain "triggers" a signal from the hypothalamus to the liver to lower its fat secretion, which Yue says is a "triglyceride-rich, very-low-density lipoprotein. Light is the co-author of Yue's paper in Nature Communications and is the director of the Alberta Diabetes Institute (ADI), where Yue is applying for membership.


"This fat complex is the kind of lipoprotein that is dangerous when its levels in the blood are elevated because it promotes atherosclerosis," she says.


The catch, though, is that this "trigger" doesn't work in obesity, a setting in which blood lipid levels are usually high. "In a model of diet-induced obesity, which then leads to insulin resistance and pre-diabetes, oleic acid no longer provides the fat-lowering trigger to the liver." Yue's findings, though, demonstrate how this faulty signal can be bypassed, unveiling potentially other ways to trigger this same function in obese patients.


This study could potentially impact how obesity and diabetes are treated, says Yue, which is the focus of her future research.


The next steps, she says, will be to look at how the brain can sense other compounds to regulate not only liver secretion of fats, but also liver glucose production, a significant contributing factor to diabetes. As a member of the Group on Molecular and Cell Biology of Lipids and with the strength of the ADI, she feels enthusiastic and inspired by her new research environment at the University of Alberta.


"It's a big field and it's emerging," says Yue about neuroscience research in the areas of metabolic disease. "Whereas the peripheral organs have gained a lot of attention in terms of how they release glucose and lipids, it's exciting to see that within the last decade and a half that the brain now is emerging as an organ that has a lot of control over our health."



More information: Nature Communications, http://ift.tt/1AZlbnD 6970.html#affil-auth


Medical Xpress on facebook

Related Stories


Researchers uncover more clues to how drug reverses obesity, diabetes, fatty liver disease


Jan 12, 2015



Researchers at the University of Michigan have identified how a promising drug in clinical trials for the treatment of obesity and related metabolic disorders improves the metabolism of sugar by generating a new signal between ...



Diabetes debate: Triglycerides form in liver despite insulin resistance


Jan 05, 2015



Solving one of the great mysteries of type 2 diabetes, a team of Yale researchers found that triglycerides, a type of fat in the blood and liver, are produced in the liver independent of insulin action in ...



Newly discovered hormone with potential treatment for obesity, type 2 diabetes, liver disease


Nov 17, 2014



Researchers at the University of Michigan have discovered how a previously unknown hormone serves as a messenger from fat cells to the liver and are investigating the potential of developing a new treatment ...



Pellino 3 protein may prevent development of obesity-driven diabetes


Jan 12, 2015



Maynooth University scientists have identified a protein in the body that may have the potential to prevent the development of obesity-driven diabetes.



Scientists identify hormone that reduces calorie burning, contributes to obesity


Dec 08, 2014



Researchers from McMaster University have identified an important hormone that is elevated in obese people and contributes to obesity and diabetes by inhibiting brown fat activity.



Recommended for you




Using stem cells to grow new hair


2 hours ago



In a new study from Sanford-Burnham Medical Research Institute (Sanford-Burnham), researchers have used human pluripotent stem cells to generate new hair. The study represents the first step toward the development ...





Human stem cells could one day be regulated to replace aged, damaged, and missing tissues


4 hours ago



When a salamander loses a tail, it grows a new one. What's the difference, MIT biologist Peter Reddien PhD '02 wondered, between a wound that severs a salamander's tail and one that severs a human spinal ...



Scientists find drug candidates can block cell-death pathway associated with Parkinson's


7 hours ago



In a pair of related studies, scientists from the Florida campus of The Scripps Research Institute (TSRI) have shown their drug candidates can target biological pathways involved in the destruction of brain cells in Parkinson's ...





Antiangiogenesis drugs could make major improvement in tuberculosis treatment


21 hours ago



Use of the same antiangiogenesis drugs that have improved treatment of some cancers could also help surmount persistent difficulties in treating tuberculosis (TB). In their PNAS Early Edition report, invest ...





Collagen fibres not only passively support bone, tendons and ligaments, but also actively contract


Jan 26, 2015



The bodies of humans and animals owe their strength especially to a fibrous structural protein called collagen. Collagen is abundant in bones, tendons, ligaments and skin. Water, a substance that is not often ...





Possible therapeutic target for common, but mysterious brain blood vessel disorder


Jan 26, 2015



Tens of millions of people around the world have abnormal, leak-prone sproutings of blood vessels in the brain called cerebral cavernous malformations (CCMs). These abnormal growths can lead to seizures, ...



User comments



Please sign in to add a comment. Registration is free, and takes less than a minute. Read more


Click here

to reset your password.


Sign in to get notified via email when new comments are made.









Categories:

0 comments:

Post a Comment